Stock Update

Evorel 50

We wish to advise you that we currently have a short-term out-of-stock of Evorel 50 (estrogen only HRT Patch).

We expect to have stock of Evorel 50 from early November.

Evorel Conti *

Evorel Conti can be considered for existing post-menopausal patients who have difficulty getting supply of their estrogen-only patch and are on a progestogen / have an intact uterus.

*Evorel Conti indication:

Hormone Replacement Therapy (HRT) for the relief of menopausal symptoms in post-menopausal women more than 6 months post-menopause.

The Evorel Range


50/170 micrograms per 24 hours transdermal patch
estradiol hemihydrate and norethisterone acetate


50 micrograms per 24 hours transdermal patch
estradiol hemihydrate

News


Webinar recording now available

Please click below to join Dr. Deirdre Lundy as she discusses “ The Most Asked Complex Questions on Menopause”


Click here to view the Most Asked Complex Questions in Menopause Webinar

Additional Consilient Health Menopause Webinars for Healthcare Professionals

In addition to the webinar above, and as part of our commitment to Healthcare Professional Education, we at Consilient Health have developed an ongoing programme of webinars for GP’sand other HCP’s on topics such as Bone Health and Vitamin D, Women’s Health – Contraception and UroGynae Topics, as well as Menopause.


Click to register for our webinars
Click to view previous webinars

Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. Please consult your doctor or nurse for further information.

If you have a medical query about a Consilient Health medicine, please contact Consilient Health at drugsafety@consilienthealth.com or +353 (0)1 2057766.

For all other queries, please contact our Irish office at Tel: +353 (0)1 2057760, Fax: +353 (0)1 2698919 or irishoffice@consilienthealth.com

Copyright ©2021 Consilient Health Ltd. All rights reserved.

The information on this website is intended for patients who have been prescribed Evorel or Evorel Conti that reside in the Republic of Ireland only.

IE-EVC-11a(10), Date of preparation: October 2024